ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MICHAEL KRIVITSKY D.O.

44405 WOODWARD AVE ST JOSEPH MERCY HOSPITAL

Pontiac | Michigan | 48351

(248) 333-7063

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,948Medicare Part D Prescriptions Filled, Including Refills

Rank: 294 out of 2035

$541K Total Retail Price of All Prescriptions

Rank: 261 out of 2035

450 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 450 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 450 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 5,656 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 545 390 1 1
OMEPRAZOLE 334 234 2 5
HYDROCODONE-ACETAMINOPHEN 322 231 S3 3 2
LISINOPRIL 314 221 4 3
AMLODIPINE BESYLATE 256 195 5 6
METFORMIN HCL 203 130 6 9
LEVOTHYROXINE SODIUM 194 144 7 4
ZOLPIDEM TARTRATE 186 149 8 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 123 89 9 26
TRIAMTERENE-HCTZ 112 85 10 35
ATENOLOL 105 78 11 10
METOPROLOL TARTRATE 101 63 12 8
FUROSEMIDE 95 87 13 7
ALLOPURINOL 95 66 13 34
LOSARTAN POTASSIUM 93 74 15 15
TAMSULOSIN HCL 88 70 16 25
PREDNISONE 86 55 17 36
ACETAMINOPHEN-CODEINE 84 65 S3 18 52
LOSARTAN-HYDROCHLOROTHIAZIDE 81 66 19 47
FLUOXETINE HCL 78 50 20 81
WARFARIN SODIUM 78 61 20 11
MELOXICAM 77 56 22 56
HYDROCHLOROTHIAZIDE 74 50 23 12
CRESTOR 69 58 24 41
RANITIDINE HCL 69 24 24 28
FLUTICASONE PROPIONATE 69 52 24 29
GABAPENTIN 68 40 27 14
HYDRALAZINE HCL 68 59 27 45
IBUPROFEN 66 0 29 43
METOPROLOL SUCCINATE 65 40 30 16
PAROXETINE HCL 59 58 31 69
LANTUS 56 11 32 40
BISOPROLOL-HYDROCHLOROTHIAZIDE 54 54 33 189
ATORVASTATIN CALCIUM 54 43 33 13
NEXIUM 53 15 35 51
DONEPEZIL HCL 52 50 36 24
ADVAIR DISKUS 50 32 37 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.